Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Vuyyuru SK, Nguyen TM, Murad MH, Narula N, Bessissow T, Zou G, McCurdy JD, Peyrin-Biroulet L, Danese S, Ma C, Singh S, Jairath V. Vuyyuru SK, et al. Among authors: zou g. Clin Gastroenterol Hepatol. 2024 Jan 6:S1542-3565(24)00003-X. doi: 10.1016/j.cgh.2023.12.023. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38185396 Review.
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.
Levesque BG, Greenberg GR, Zou G, Sandborn WJ, Singh S, Hauenstein S, Ohrmund L, Wong CJ, Stitt LW, Shackelton LM, King D, Lockton S, Ducharme J, Feagan BG. Levesque BG, et al. Among authors: zou g. Aliment Pharmacol Ther. 2014 May;39(10):1126-35. doi: 10.1111/apt.12733. Epub 2014 Apr 1. Aliment Pharmacol Ther. 2014. PMID: 24689499 Free article. Clinical Trial.
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, Sandborn WJ, Feagan BG. Mosli MH, et al. Among authors: zou g. Am J Gastroenterol. 2015 Jun;110(6):802-19; quiz 820. doi: 10.1038/ajg.2015.120. Epub 2015 May 12. Am J Gastroenterol. 2015. PMID: 25964225 Review.
Development and validation of a histological index for UC.
Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Shackelton LM, Walker CW, Nelson S, Vandervoort MK, Frisbie V, Samaan MA, Jairath V, Driman DK, Geboes K, Valasek MA, Pai RK, Lauwers GY, Riddell R, Stitt LW, Levesque BG. Mosli MH, et al. Among authors: zou g. Gut. 2017 Jan;66(1):50-58. doi: 10.1136/gutjnl-2015-310393. Epub 2015 Oct 16. Gut. 2017. PMID: 26475633
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Jairath V, Zou G, Parker CE, Macdonald JK, Mosli MH, Khanna R, Shackelton LM, Vandervoort MK, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, Koutsoumpas A, Minas E, Samaan MA, Travis S, D'Haens G, Levesque BG, Sandborn WJ, Feagan BG. Jairath V, et al. Among authors: zou g. J Crohns Colitis. 2016 May;10(5):607-18. doi: 10.1093/ecco-jcc/jjw004. Epub 2016 Jan 7. J Crohns Colitis. 2016. PMID: 26746169 Free PMC article. Review.
Efficient Early Drug Development for Ulcerative Colitis.
Khanna R, Jairath V, Vande Casteele N, Mosli MH, Zou G, Parker CE, Levesque BG, Sandborn WJ, D'Haens G, Feagan BG. Khanna R, et al. Among authors: zou g. Gastroenterology. 2016 May;150(5):1056-1060. doi: 10.1053/j.gastro.2016.03.013. Epub 2016 Mar 24. Gastroenterology. 2016. PMID: 27018491 No abstract available.
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
Khanna R, Nelson SA, Feagan BG, D'Haens G, Sandborn WJ, Zou GY, MacDonald JK, Parker CE, Jairath V, Levesque BG. Khanna R, et al. Among authors: zou gy. Cochrane Database Syst Rev. 2016 Aug 8;2016(8):CD010642. doi: 10.1002/14651858.CD010642.pub2. Cochrane Database Syst Rev. 2016. PMID: 27501379 Free PMC article. Review.
Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
Khanna R, Zou G, Stitt L, Feagan BG, Sandborn WJ, Rutgeerts P, McDonald JWD, Dubcenco E, Fogel R, Panaccione R, Jairath V, Nelson S, Shackelton LM, Huang B, Zhou Q, Robinson AM, Levesque BG, D'Haens G. Khanna R, et al. Among authors: zou g. Am J Gastroenterol. 2017 Oct;112(10):1584-1592. doi: 10.1038/ajg.2016.580. Epub 2017 Jan 10. Am J Gastroenterol. 2017. PMID: 28071654 Clinical Trial.
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease.
Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, Kherad O, Koutsoumpas A, Minas E, Restellini S, Samaan MA, Khanna R, Levesque BG, D'Haens G, Sandborn WJ, Feagan BG. Jairath V, et al. Among authors: zou g. Aliment Pharmacol Ther. 2017 Apr;45(8):1021-1042. doi: 10.1111/apt.13973. Epub 2017 Feb 5. Aliment Pharmacol Ther. 2017. PMID: 28164348 Review.
1,921 results